Three years of qualification
Audited Supplier
In This Store
Jiangsu Aosaikang Pharmaceutical Co. Ltd. (ASK Pharm) was founded in January 2003, and is a research-based pharmaceutical enterprise that integrates and streamlines innovative research and development with manufacture, marketing promotion and sales of proprietary pharmaceuticals, fine chemicals and health-care products. The company underwent corporate restructuring in July 2011 to further improve its organization efficacy and production capacity. At present, ASK Pharm has established a systematical administration and operation structure, with comprehensive management system, superior R&D facility, state-of-the-art manufacturing capacity, sustainable product quality assurance, professional sales network, and after-marketing drug use monitoring and surveillance.
ASK Pharm has always prioritized proprietary product innovation and optimization. By 2011, the company held 64 proprietary inventions or patents, including 35 product patents and 29 package design patents. The company has obtained 77 product registration certificates from the SFDA, which included 64 certificates for proprietary parenteral injectables and 13 certificates for API. There are five research institutes under the ASK Pharm banner, i.e., Nanjing Haiguang Applied Chemistry Research Institute, ASK Institute for Drug Delivery Systems, ASK Biotech Institute, ASKGene Pharma USA, and ASK Chiral Research Center. These research institutes are the core sources contributing to a healthy and successful growth of the company.
Year of Establishment: 2003
Total Assets(USD): More than 1000,000,000
Total Number of Staff: less than 10 person
Main Competitive Advantages: Brandname,Experienced R&D Staff,Production capacity,Large Product Line,Quality Service
Other Competitive Advantages: ASK Pharm is a key hi-tech enterprises of the National Torch Program that integrates and streamlines innovative research and development with manufacture, marketing promotion and sales of pharmaceuticals products. Its annual sales revenue has reached over ￥3 billion（$ 484million）in 2014. ASK Pharm specializes in proton pump inhibitor (PPI) products and oncology medicines. It is one of the leading figures in PPI injections researching, manufacturing and marketing companies. 2300 employees in all R&D R & D platform for biological and chemical medicine 6 R&D institutes Nanjing Haiguang Applied Chemistry Institute I , LTD. Nanjing Haiguang Applied Chemistry InstituteⅡ, LTD. ASK DDS Research Institute(DDS) Chiral Drug Research Institute ASK Biotech Institute AskGene Pharma, Inc.( US) “Best R&D Pipeline Pharmaceutical Manufactures” for 5 consecutive years “Top Twenty National R&D Innovators” for 3 consecutive years We are hunting for newest scientific and technical achievements in our core therapeutic areas including cancer, digestive system diseases, diabetes and deep infection on a global scale. Lyo-powder lines and small volume injection lines meeting with China GMP certification requirements. Major equipments are of famous first-rate international brands or JV brands, and production facilities have reached international advanced level Automatic washing, filling and packing system, Automatic loading and unloading system Automatic light inspection machine Automatic packing system imported from Italy Annual capacity of Lyopowder lines and small volume injection lines have reached 50 million vials and will double to 100 million vials after 2th phase plant is put into use. Annual capacity of 2 to-be -added OSD lines ( 1 anti-cancer line and 1 ordianary line) will be 100 million tablets. Quality: Received 15 GMP certifications from state and provincial FDA until the end of 2014 in total. The first enterprise in Nanjing to have passed the new version GMP certification. l Powerful comprehensive strength: Ø Ranked NO.71 in top 100 pharmaceutical manufacturing companies, 2014 l Strong R&D capability Ø 5％ revenue back into R&D investment annually( around 80 million) Ø 244 pharmaceutical scientists l Extensive product line Ø 38 marketed FDFs, 16 marketed APIs, 32 pipeline FDFs, 25 pipeline APIs l Adequate preparation to enter regulated markets Ø Hardware: n NEW API PLANT constructed according to EU GMP & cGMP standards（$20mil investment） n 2th phase FDF plant constructed according to EU GMP & cFDA standards（$100mil investment） n State of the art facilities (Branded equipment)
Patents and Copyrights: 114 pharmaceutical patents in all
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
